This website will be unavailable from Thursday, May 30, 2024 at 6:00 p.m. through Monday, June 3, 2024 at 7:00 a.m. due to data center maintenance.
Amend CSSB 200 (senate committee report) in ARTICLE 3 of the bill as follows:
(1) In SECTION 3.08(b), in added Section 531.0736(c)(1), Government Code (page 34, line 69), strike "and".
(2) In SECTION 3.08(b), in added Section 531.0736(c)(2), Government Code, between "pharmacist" and the underlined period (page 35, line 3), insert the following:
; (3) include at least 17 physicians and pharmacists who:
(A) provide services across the entire population of Medicaid recipients and represent different specialties, including at least one of each of the following types of physicians:
(i) a pediatrician;
(ii) a primary care physician;
(iii) an obstetrician and gynecologist;
(iv) a child and adolescent psychiatrist; and
(v) an adult psychiatrist; and
(B) have experience in either developing or practicing under a preferred drug list; and
(4) include a consumer advocate who represents Medicaid recipients
(3) In SECTION 3.08(b), in added Section 531.0736, Government Code (page 35, between lines 3 and 4), insert the following:
(c-1) The executive commissioner by rule shall develop and implement a process by which a person may apply to become a member of the board and shall post the application and information regarding the application process on the commission's Internet website.
(4) In SECTION 3.08(b), in added Section 531.0736(d)(2), Government Code (page 35, line 7), strike "otherwise".
(5) In SECTION 3.08(b), in added Section 531.0736(f), Government Code (page 35, line 11), after the underlined period, insert "The presiding officer must be a physician.".
(6) In SECTION 3.08(b), in added Section 531.0736(g), Government Code (page 35, line 14), between "lists" and the underlined period, insert ", the adoption of or changes to drug use criteria, or the adoption of prior authorization or drug utilization review proposals".
(7) In SECTION 3.08(b), in added Section 531.0736(k), Government Code (page 35, lines 46 and 47), strike "cost-effective medically appropriate drug therapies for Medicaid recipients" and substitute "a range of clinically effective, safe, cost-effective, and medically appropriate drug therapies for the diverse segments of the Medicaid population".
(8) In SECTION 3.08(c), in redesignated and amended Section 531.0737(a), Government Code (page 36, line 2) between "(a) A" and "member", insert "voting".
(9) In SECTION 3.08(c), in redesignated and amended Section 531.0737(a), Government Code (page 36, line 6), between "assist" and "in the", insert "in the development of the preferred drug lists or".
(10) Strike SECTIONS 3.08(h) and (i) (page 37, lines 8 through 25) and substitute the following:
(h) The term of a member serving on the Medicaid Drug Utilization Review Board on September 1, 2015, expires on October 31, 2015. Not later than November 1, 2015, the executive commissioner of the Health and Human Services Commission shall appoint the initial members to the Drug Utilization Review Board in accordance with Section 531.0736, Government Code, as added by this article, for terms beginning November 1, 2015. In making the initial appointments and notwithstanding Section 531.0736(e), Government Code, as added by this article, the executive commissioner shall designate as close to one-half as possible of the members to serve for terms expiring November 1, 2017, and the remaining members to serve for terms expiring November 1, 2019.
(i) Not later than October 1, 2015, and before making initial appointments to the Drug Utilization Review Board as provided by Subsection (h) of this section, the executive commissioner of the Health and Human Services Commission shall adopt and implement the application process required under Section 531.0736(c-1), Government Code, as added by this article.
(j) Not later than January 1, 2016, and except as provided by Subsection (i) of this section, the executive commissioner of the Health and Human Services Commission shall adopt or amend rules as necessary to reflect the changes in law made to the Drug Utilization Review Board under Section 531.0736, Government Code, as added by this article, including rules that reflect the changes to the board's functions and composition.